Skip to main content
    H

    Heartflow, Inc. Common Stock (HTFL)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $50.91
    +1.45 (+2.92%)

    Market Cap: $4.30B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    60%(3/5)
    Avg Surprise
    -76.39%
    Streak
    3 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.10
    Range$-0.14 - $-0.08
    9 analysts
    EPS Revisions
    4
    0
    7d
    4
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.11+6.5%
    60d ago$-0.11+5.4%
    30d ago$-0.10+1.2%
    7d ago$-0.10+0.1%
    Current$-0.10
    Revenue Consensus
    $65M
    Range$65M - $66M
    9 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.00
    Range$-0.05 - $0.03
    9 analysts
    Revenue Consensus
    $77M
    Range$76M - $79M
    10 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.00---
    Sep 26EST
    		-$-0.10---
    Jun 26
    Reported Aug 13
    		$-0.16$-0.22+27.27%Beat+85.5%
    Mar 26
    Reported May 14
    		$-0.16$-0.17+5.88%Beat-
    Dec 25
    Reported Mar 18
    		$-0.12$-0.15+21.20%Beat-
    Sep 25
    Reported Nov 12
    		$-0.27$-0.24-12.50%Miss-
    Jun 25
    Reported Sep 19
    		$-1.10$-0.21-423.81%Miss-

    Key Metrics

    Valuation
    P/E Ratio-71.88EV/EBITDAN/A
    Price/FCF-74.32xFCF Yield-1.35%
    Profitability
    Profit Margin-55.80%Operating Margin-27.90%
    ROE-154.20%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio5.08xQuick Ratio5.08x
    Trading Statistics
    BetaN/AAvg Volume1.87M
    52-Week High$54.3252-Week Low$20.13

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$50.02
    SMA 20$49.75
    SMA 50$46.44
    SMA 200$32.77
    EMA 10$49.96
    EMA 20$49.43
    EMA 50$45.63
    EMA 200$35.96

    MACD

    Line: 1.05Signal: 1.32Hist: -0.26

    ADX

    ADX: 21.5+DI: 20.1-DI: 20.8

    Aroon & PSAR

    Aroon Up72.0
    Aroon DownN/A
    PSAR$53.57

    Bollinger Bands

    Upper Band$51.98
    Lower Band$47.53
    %B Position894%(Upper)
    Band Width0.76

    RSI (14-Day)

    Neutral
    57.4

    Momentum Oscillators

    Stoch %K47.7
    Stoch %D47.1
    Williams %R-43.7
    ROC (10d)4.1%
    Momentum2.00
    CCI (20d)24.6
    MFI (14d)52.9

    Volatility Measures

    ATR (14d)$2.69(5.3%)
    StdDev (20d)1.11
    Hist Vol44.1%(High)

    Volume Flow

    VWAP$50.05
    OBV49.1M
    AD Line-911.6K
    CMF (20d)-0.047

    Volume Metrics

    Avg Vol (20d)1.9M
    Vol Ratio0.8x
    VWMA (20d)$49.92

    Pivot Points

    R3$52.62
    R2$51.75
    R1$50.60
    Pivot Point$49.73
    S1$48.58
    S2$47.71
    S3$46.56

    Advanced Oscillators

    TSI13.38
    Ultimate Osc51.7
    KST48.86

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    Total Revenue$64.08M$52.59M$49.13M$46.28M$43.42M$37.20M$34.98M$32.93M$31.05M$26.84M
    Cost of Revenue$10.89M$10.42M$10.07M$10.86M$10.65M$9.26M$8.73M$8.00M$7.21M$7.42M
    Gross Profit$53.19M$42.16M$39.06M$35.41M$32.78M$27.94M$26.25M$24.94M$23.84M$19.42M
    Operating Expenses$71.09M$71.67M$56.81M$50.51M$46.49M$45.44M$42.31M$39.87M$38.02M$35.48M
    R&D$26.26M$21.62M$18.66M$17.30M$15.03M$13.92M$12.28M$11.86M$9.93M$9.44M
    SG&A$44.83M$42.57M$38.15M$33.22M$31.46M$31.52M$30.03M$28.00M$28.08M$26.04M
    Operating Income$-17,900,000$-29,504,000$-17,750,000$-15,099,000$-13,715,000$-17,502,000$-16,058,000$-14,929,000$-14,177,000$-16,058,000
    Interest Income$2.31M$2.46M$2.63M$1.73M$635,000$543,000$592,000$820,000$1.14M$1.51M
    Interest Expense$0$3,000$8,000$9.81M$6.62M$5.09M$5.15M$5.30M$6.08M$6.24M
    Income Before Tax$-15,721,000$-27,357,000$-24,560,000$-50,825,000$-9,137,000$-32,345,000$-32,970,000$-19,140,000$-23,259,000$-21,004,000
    Income Tax Expense$22,000$23,000$-165,000$30,000$59,000$0$5,000$0$120,000$-72,000
    Net Income$-15,743,000$-27,380,000$-24,395,000$-50,855,000$-9,196,000$-32,345,000$-32,975,000$-19,140,000$-23,379,000$-20,932,000
    EBITDA$-16,366,000$-28,220,000$-22,306,000$-39,049,000$1.76M$-24,701,000$-25,483,000$-12,449,000$-18,326,000$-12,888,000
    EBIT$-18,026,000$-29,818,000$-24,552,000$-42,739,000$-3,151,000$-27,795,000$-27,818,000$-14,662,000$-18,326,000$-14,761,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about HTFL

    News

    Form 4 Heartflow Inc: John C.M. Farquhar (Director, CEO) For: 12 October

    This article reports on a Form 4 filing for Heartflow Inc., detailing an insider transaction by John C.M. Farquhar, who serves as a Director and CEO...

    Investing.com Nigeria•10/14/26•Neutral

    Form 4 Heartflow Inc: John C.M. Farquhar (Director, CEO) For: 12 October

    This article reports on a Form 4 filing for Heartflow Inc (HTFL) concerning John C.M. Farquhar, who serves as both a Director and CEO of the company. The filing pertains to activity on October 12. The article provides...

    Investing.com Canada•10/14/26•Neutral

    Heartflow CEO John Farquhar sells $1.93 million in stock

    Heartflow CEO John C.M. Farquhar sold 38,900 shares of the company's common stock for approximately $1.93 million on October 12, 2026...

    Investing.com•10/14/26•Somewhat-Bearish

    Under a trading plan, Heartflow (HTFL) CEO sells 38,900 shares and retains 283,014 directly.

    Heartflow (HTFL) CEO John C.M. Farquhar sold 38,900 shares of common stock on October 12, 2026, at a weighted average price of $49.5680 per share...

    Stock Titan•10/14/26•Bearish

    HeartFlow Inc (HTFL) CEO John Farquhar Sells 38,900 Shares

    HeartFlow Inc (HTFL) CEO John Farquhar sold 38,900 shares of the company on October 12, 2026, retaining 283,014 shares. This transaction is part of a broader trend of insider selling at HeartFlow...

    GuruFocus•10/14/26•Somewhat-Bearish

    HTFL Valuation and Fair Value

    P/E
    -71.9x
    P/FCF
    -74.3x
    P/B
    15.7x
    See GNG's fair value

    HTFL Profitability: Margins, ROIC and FCF

    Gross margin
    80.1%
    Operating margin
    -27.9%
    Net margin
    -55.8%
    ROE
    -154.2%
    FCF margin
    -27.9%
    FCF yield
    -1.3%

    HTFL Competitors

    CompanyTicker
    Integer Holdings CorpITGR
    LivaNova PLCLIVN
    Diversified Healthcare TrustDHCNL
    Dianthus Therapeutics Inc.DNTH
    Akero Therapeutics IncAKRO
    ICU Medical IncICUI
    Amicus Therapeutics IncFOLD
    Regencell Bioscience Holdings LtdRGC

    Sector: Healthcare

    HTFL Analyst Ratings

    Consensus
    Buy
    Analysts
    10
    Strong Buy
    2
    Buy
    6
    Hold
    2
    Sell
    0
    Strong Sell
    0

    HTFL Bull Case vs Bear Case

    Bull case

    • HTFL grew quarterly revenue 47.6% year over year.
    • 80.0% of HTFL's analyst ratings are Buy or Strong Buy.

    Bear case

    • HTFL has a -55.8% net profit margin.

    HTFL Earnings: Beat Rate and Next Report

    Beat rate
    3 of 5 quarters (60.0%)
    Average surprise
    -76.4%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.10
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    4 up, 2 down

    Frequently Asked Questions About HTFL

    Does HTFL pay dividends?

    Heartflow, Inc. Common Stock (HTFL) does not currently pay a regular dividend.

    What is HTFL's market cap?

    Heartflow, Inc. Common Stock (HTFL) has a market capitalization of $4.30B with a current stock price of $50.91.

    Related stocks

    Sector: Healthcare

    All stocks starting with H

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In